Literature DB >> 1349197

Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population.

A von Eckardstein1, H Funke, M Schulte, M Erren, H Schulte, G Assmann.   

Abstract

The aims of this study were to detect polymorphic sites in the apolipoprotein (apo) A-IV gene, to establish their frequencies, to determine potential haplotypes, and to investigate the role of these polymorphisms in lipid metabolism. A sequencing study of four individuals led to the identification of two synonymous mutations (codons 9 and 54) and three nonsynonymous mutations (Val-8----Met, Gln360----His, and Thr347----Ser) and of a VNTR polymorphism within a series of three or four CTGT repeats in the noncoding region of exon 3. Frequencies of these polymorphisms were determined in 291 students by using naturally occurring (BstEII for the synonymous mutation in codon 54, HinfI for Thr347----Ser, and Fnu4HI for Gln360----His) or artificially introduced restriction-enzyme cutting sites (BstEII for the synonymous mutation in codon 9 and MamI for Val-8----Met), subsequent to PCR amplification. The four-base deletion/insertion polymorphism and its localization cis or trans to the mutations in codons 347 and 360 were studied by direct sequencing of PCR-amplified DNA from 87 students. Frequencies of the rarer alleles were .007 for apo A-IV-8:Met, .04 for the synonymous mutation in codon 9, .14 for the synonymous mutation in codon 54, .16 for apo A-IV347:Ser, .07 for apo A-IV360:His, and .39 for the four-base of insertion. Apo A-IV360:His in all cases was cis-localized to the (CTGT)3 repeat and apo A-IV347:Thr; and apo A-IV347:Ser was cis-localized to the (CTGT)4 repeat and apo A-IV360:Gln. Four haplotypes formed from these three polymorphic sites were thus found. The apo A-IV347:Ser allele was associated both with significantly lower plasma apo B concentrations in both sexes and with significantly lower LDL-cholesterol concentrations in men. Heterozygous carriers of apo A-IV360:His exhibited significantly higher concentrations of LDL-cholesterol and lower Lp(a) concentrations, compared with apo A-IV360:Gln homozygotes. We could not confirm the previously reported association of apo A-IV360:His with elevated HDL-cholesterol concentrations. In the population, the Val-8----Met polymorphism was not associated with significantly different lipid concentrations, but in a family study the Met-8 allele was associated with lower HDL-cholesterol and higher LDL-cholesterol concentrations. In conclusion, our results indicate an important role of the apo A-IV gene locus in the metabolism of apo B and, to a lesser extent, apo A-I containing lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349197      PMCID: PMC1682587     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  45 in total

1.  Macrophage interaction of HDL subclasses separated by free flow isotachophoresis.

Authors:  G Nowicka; T Brüning; A Böttcher; G Kahl; G Schmitz
Journal:  J Lipid Res       Date:  1990-11       Impact factor: 5.922

2.  Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24.

Authors:  A P Wojciechowski; M Farrall; P Cullen; T M Wilson; J D Bayliss; B Farren; B A Griffin; M J Caslake; C J Packard; J Shepherd
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

3.  Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I.

Authors:  G M Anantharamaiah; Y V Venkatachalapathi; C G Brouillette; J P Segrest
Journal:  Arteriosclerosis       Date:  1990 Jan-Feb

4.  A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity.

Authors:  H Funke; A von Eckardstein; P H Pritchard; J J Albers; J J Kastelein; C Droste; G Assmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterisation.

Authors:  U Beisiegel; G Utermann
Journal:  Eur J Biochem       Date:  1979-02-01

6.  The mutation causing the common apolipoprotein A-IV polymorphism is a glutamine to histidine substitution of amino acid 360.

Authors:  H Tenkanen; M Lukka; M Jauhiainen; J Metso; M Baumann; L Peltonen; C Ehnholm
Journal:  Arterioscler Thromb       Date:  1991 Jul-Aug

7.  Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age.

Authors:  M Sandkamp; H Funke; H Schulte; E Köhler; G Assmann
Journal:  Clin Chem       Date:  1990-01       Impact factor: 8.327

8.  Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification.

Authors:  G Utermann; U Beisiegel
Journal:  Eur J Biochem       Date:  1979-09

9.  Isolation and characterization of human apolipoprotein A-IV from lipoprotein-depleted serum.

Authors:  R B Weinberg; A M Scanu
Journal:  J Lipid Res       Date:  1983-01       Impact factor: 5.922

10.  Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas.

Authors:  C L Hanis; T C Douglas; D Hewett-Emmett
Journal:  Hum Genet       Date:  1991-01       Impact factor: 4.132

View more
  3 in total

1.  Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection.

Authors:  S Rust; H Funke; G Assmann
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

2.  Minor allele of the APOA4 gene T347S polymorphism predisposes to obesity in postmenopausal Turkish women.

Authors:  Filiz Guclu-Geyik; Altan Onat; Neslihan Coban; Evrim Komurcu-Bayrak; Vedat Sansoy; Günay Can; Nihan Erginel-Unaltuna
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

3.  Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein.

Authors:  D J Rader; J Schäfer; P Lohse; B Verges; M Kindt; L A Zech; A Steinmetz; H B Brewer
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.